Blog

Russ Cohen

Tesla vs. Alphabet: Who Wins the Autonomous AI Race?

Key Points Both Tesla and Alphabet are betting heavily on autonomous driving. Tesla is manufacturing its own robotaxis, while Alphabet’s Waymo subsidiary is outsourcing much of its vehicle manufacturing. 10 stocks we like better than Alphabet › Both Tesla (NASDAQ: TSLA) and Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) have invested billions of dollars over many years to ...

Russ Cohen

Microsoft Is Spending Billions on AI, But Investors Aren’t Buying It

delivered what, by almost any conventional measure, was a spectacular quarter. Revenue climbed, cloud growth re-accelerated, and Azure posted numbers that beat even the most optimistic analyst models. On paper, this is a company firing on every cylinder. And yet MSFT shares have shed roughly 15% in 2026, underperforming the broader market at a time ...

Russ Cohen

Is Co-Diagnostics National Security’s Next Diagnostic Pick?

A structural shift is underway in the biodefense landscape. The declaration of a Public Health Emergency of International Concern (PHEIC) by the World Health Organization on May 17, 2026, for the Bundibugyo virus Ebola outbreak should be seen by investors as more than a headline, because it is a fundamental catalyst. This declaration compels sovereign ...

Russ Cohen

Apple Stock Hits New Record Highs as AI Doubts Begin to Fade

As the most searched for stock on Zacks.com, Apple’s AAPL) remarkable rally has accelerated in recent weeks.  Apple has once again captured Wall Street’s full attention as investors pile back into mega-cap technology stocks, with analysts growing increasingly optimistic that the iPhone maker’s artificial intelligence strategy may finally be gaining traction. Reclaiming its spot among ...

Russ Cohen

As Big Pharma Bets On Radiopharmaceuticals, Aptevo And Niowave Join Forces To Advance Novel Targeted Cancer Therapeutics In The $17B+ Oncology Category

As Big Pharma Bets On Radiopharmaceuticals, Aptevo And Niowave Join Forces To Advance Novel Targeted Canc – Benzinga When it comes to treating metastatic cancers, the current approach is to destroy everything in the path to the tumor. But the collateral damage from that can be deadly.  For good reason: this search-and-destroy approach may be ...

Russ Cohen

Stocks Face Liquidity Test as Bitcoin Nears Key Support

was flat on the day, finishing up just 2 bps. Overall, it was a bit of a snooze fest. The main takeaway is that today begins a nearly $150 billion liquidity drain, starting with $15 billion in T-bills settling, followed by $47 billion in coupon settlements on Friday, $68 billion on Monday, and another $16 ...